Figure 3.
Combined drug exposure of ARS and DHA to illustrate antimalarial effect concentrations in pregnant women treated with intravenous and oral artesunate who were mildly or moderately unwell with uncomplicated malaria
Combined drug exposure of ARS and DHA to illustrate antimalarial effect concentrations in pregnant women treated with intravenous and oral artesunate who were mildly or moderately unwell with uncomplicated malaria